Second Sight Medical Products Inc EYES
We take great care to ensure that the data presented and summarized in this overview for SECOND SIGHT MEDICAL PRODUCTS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in EYES
Top Purchases
Top Sells
About EYES
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Insider Transactions at EYES
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
3,968,253
+45.8%
|
$3,968,253
$1.26 P/Share
|
|
Oct 03
2024
|
Donald Dwyer Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.99%
|
$500
$1.13 P/Share
|
|
Oct 02
2024
|
Donald Dwyer Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.98%
|
$1,000
$1.13 P/Share
|
|
Oct 01
2024
|
Donald Dwyer Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+2.02%
|
$1,000
$1.14 P/Share
|
|
Jul 31
2024
|
Donald Dwyer Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+7.77%
|
$4,000
$1.23 P/Share
|
|
Jul 30
2024
|
Donald Dwyer Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+10.31%
|
$5,000
$1.24 P/Share
|
|
Feb 15
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
1,078
+0.15%
|
$1,078
$1.01 P/Share
|
|
Feb 09
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
1,071
+0.15%
|
$1,071
$1.01 P/Share
|
|
Feb 08
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
1,119
+0.15%
|
$1,119
$1.01 P/Share
|
|
Feb 06
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
56
+0.01%
|
$56
$1.01 P/Share
|
|
Feb 05
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
1,939
+0.27%
|
$1,939
$1.01 P/Share
|
|
Jan 31
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
100
+0.01%
|
$100
$1.01 P/Share
|
|
Jan 23
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
834
+0.12%
|
$834
$1.01 P/Share
|
|
Jan 22
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
7,620
+1.05%
|
$7,620
$1.01 P/Share
|
|
Jan 19
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
77
+0.01%
|
$77
$1.01 P/Share
|
|
Jan 18
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
999
+0.14%
|
$999
$1.01 P/Share
|
|
Jan 16
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
13,067
+1.8%
|
$13,067
$1.01 P/Share
|
|
Jan 08
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
6,731
+0.95%
|
$6,731
$1.08 P/Share
|
|
Jan 05
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
2,000
+0.29%
|
$2,000
$1.08 P/Share
|
|
Jan 04
2024
|
Gregg Williams Director |
BUY
Open market or private purchase
|
Direct |
4,200
+0.6%
|
$4,200
$1.07 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 4.23M shares |
|---|